Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact 841DB59E-BE37-11E5-B977-9926B5D1D7B1 cql: author exact F5E43E34-F0ED-11E1-A9DE-61C894A0A6B4

Add to list
- Journal Article
- A1
- open access
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia

André Pedro Pinto De Almeida (UGent) , Sara T'Sas (UGent) , Luca Pagliaro (UGent) , Igor Fijalkowski (UGent) , Wouter Sleeckx (UGent) , Hannah Van Steenberge (UGent) , Raffaella Zamponi, Béatrice Lintermans (UGent) , Wouter Van Loocke (UGent) , Bruno Palhais (UGent) , et al.

(2024) HEMASPHERE. 8(3).
Add to list
- Journal Article
- A1
- open access
Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

Steven Goossens (UGent) , Anje Cauwels (UGent) , Tim Pieters (UGent) , Renate De Smedt (UGent) , Sara T'Sas (UGent) , André Pedro Pinto De Almeida (UGent) , Willem Daneels (UGent) , Pieter Van Vlierberghe (UGent) and Jan Tavernier (UGent)

(2022) HAEMATOLOGICA. 107(6). p.1448-1453
Add to list
- Journal Article
- A1
- open access
Myb drives B-cell neoplasms and myeloid malignancies in vivo

Tim Pieters (UGent) , André Pedro Pinto De Almeida (UGent) , Sara T'Sas (UGent) , Kelly Lemeire (UGent) , Tino Hochepied (UGent) , Geert Berx (UGent) , Alex Kentsis, Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2022) BLOOD ADVANCES. 6(10). p.2987-2991
Add to list
SOX11 functions as an oncogene in Lmo2-driven T-cell lymphoblastic leukemia (T-ALL)

André Pedro Pinto De Almeida (UGent) , Tim Pieters (UGent) , Sara T'Sas (UGent) , Steven Goossens (UGent) and Pieter Van Vlierberghe (UGent)

(2021) BLOOD. In Blood 138(Supplement 1). p.1136-1137
Add to list
- Journal Article
- A1
- open access
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice

Tim Pieters (UGent) , Sara T'Sas (UGent) , Stijn Vanhee (UGent) , André Pedro Pinto De Almeida (UGent) , Yasmine Driege (UGent) , Juliette Roels (UGent) , Wouter Van Loocke (UGent) , Willem Daneels (UGent) , Mathijs Baens, Arnaud Marchand, et al.

(2021) JOURNAL OF EXPERIMENTAL MEDICINE. 218(10).
Add to list
- Journal Article
- A1
- open access
Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies

Tim Pieters (UGent) , Sara T'Sas (UGent) , Lisa Demoen (UGent) , André Pedro Pinto De Almeida (UGent) , Lieven Haenebalcke (UGent) , Filip Matthijssens (UGent) , Kelly Lemeire (UGent) , Jinke D'Hont (UGent) , Frédérique Vanrockeghem (UGent) , Tino Hochepied (UGent) , et al.

(2019) SCIENTIFIC REPORTS. 9.
Add to list
- Journal Article
- A1
- open access
ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms

Steven Goossens (UGent) , Jueqiong Wang, Cedric Tremblay, Jelle De Medts (UGent) , Sara T'Sas (UGent) , Thao Nguyen, Jesslyn Saw, Katharina Haigh, David J Curtis, Pieter Van Vlierberghe (UGent) , et al.

(2019) HAEMATOLOGICA. 104(8). p.1608-1616
Add to list
- Conference Paper
- C3
Cyclin D2 overexpression recapitulates mantle cell lymphoma in mice

Tim Pieters (UGent) , Steven Goossens (UGent) , Sara T'Sas (UGent) , Geert Berx (UGent) , Jody J Haigh and Pieter Van Vlierberghe (UGent)

(2016) BLOOD. 128(22).
Add to list
- Conference Paper
- C3
Fast generation of conditional ROSA26-based mouse models that recapitulate genomic events in human T-ALL

Tim Pieters (UGent) , Steven Goossens (UGent) , Sara T'Sas (UGent) , Lieven Haenebalcke (UGent) , Tino Hochepied (UGent) , Béatrice Lintermans (UGent) , Sofie Peirs (UGent) , Filip Matthijssens (UGent) , J Haigh, Geert Berx (UGent) , et al.

(2016) HAEMATOLOGICA. 101(suppl. 1). p.322-322

Academic Bibliography

Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia

Direct and indirect anti-leukemic properties of Activity-on-Target interferons for the treatment of T-cell acute lymphoblastic leukemia

Myb drives B-cell neoplasms and myeloid malignancies in vivo

SOX11 functions as an oncogene in Lmo2-driven T-cell lymphoblastic leukemia (T-ALL)

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice

Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies

ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms

Cyclin D2 overexpression recapitulates mantle cell lymphoma in mice

Fast generation of conditional ROSA26-based mouse models that recapitulate genomic events in human T-ALL

Contents

Support

Contact